Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-042326

Principal Accounting Officer sold 272 shares at $84.94 ($23,104)

  • Principal Accounting Officer acquired 272 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Alenson Carman Principal Accounting Officer 2018-07-09 Option exercise +272 $52.29 $14,223 272 D
Alenson Carman Principal Accounting Officer 2018-07-09 Sale −272 $84.94 $23,104 0 D
Derivatives
Alenson Carman Principal Accounting Officer 2018-07-09 Option exercise · Stock option (right to buy) −272 12,578 D
Open-market sales · 272 sh · avg $84.94 · $23,104
Loading xslF345X03/doc4.xml…